A recent study showed that the DREAM/HDAC4/HDAC5 complex epigenetically down-regulates ncx3 gene transcription after stroke, and the pharmacological inhibition of class IIa HDACs reduces stroke-induced neurodetrimental effects [40]. The gene discussed is HDAC4; the disease is Stroke.